乳酸及乳酸清除率对脓毒症重症患者院内死亡预测的附加价值
该回顾性观察性队列研究纳入荷兰莱顿大学医学中心混合ICU 2006年至2018年1月收治的451例成人脓毒症患者,比较在APACHE IV基线模型上加入13种预先设定的乳酸及乳酸清除率组合(0、6、24小时)的扩展模型对院内死亡的预测价值。160例院内死亡,其中106例ICU内死亡。幸存者各时间点乳酸及乳酸清除率均高于死亡者。13个扩展模型中10个AIC改善,以加入24小时乳酸(单独或联合入院乳酸或24小时乳酸清除率)的模型表现最佳。与基线APACHE IV模型相比,最佳模型(APACHE IV+24小时乳酸)使特异性提高29.9%(95%CI 18.9-40.9%)。
要点
- 脓毒症成人ICU患者入院24小时乳酸加入APACHE IV模型,预测院内死亡特异性提高29.9%(95%CI 18.9-40.9%)。
- 13个预设扩展模型中10个AIC评分改善,最佳为含24小时乳酸(单独或联合入院乳酸或24小时乳酸清除率)的模型。
- 451例脓毒症ICU患者中160例院内死亡(106例ICU内死亡),死亡者各时间点乳酸及乳酸清除率均高于幸存者。
- 该研究为回顾性观察性队列,结论需外部验证以开发扩展预测模型。
适用人群与场景
- 荷兰莱顿大学医学中心混合ICU 2006年至2018年1月收治的成人脓毒症患者,共451例符合纳入标准(来自603例ICU入住记录)。
研究设计与关键结果
- 研究类型:回顾性观察性队列研究;单中心(荷兰莱顿大学医学中心混合ICU);样本量451例脓毒症成人ICU患者;无干预。
- 主要结果:160例院内死亡(其中106例ICU内死亡);死亡者各时间点乳酸及乳酸清除率均高于幸存者。
- 模型比较:在APACHE IV基线模型上加入13种预设乳酸/乳酸清除率组合(0、6、24小时),10/13个扩展模型AIC改善,最佳为含24小时乳酸(单独或联合入院乳酸或24小时乳酸清除率)的模型。
- 最佳模型(APACHE IV+24小时乳酸)与基线APACHE IV比较:特异性提高29.9%(95%CI 18.9-40.9%)。
证据类型、等级与局限
- 证据类型:回顾性观察性队列研究。
- 局限:原文报告需外部验证以开发扩展预测模型。
对床旁实践的改变
- 在脓毒症成人ICU患者中,入院24小时乳酸测量可能为APACHE IV的院内死亡预测增加价值(作者结论)。
- 作者认为需外部验证以开发扩展预测模型。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: We investigated the added predictive value of lactate and lactate clearance to the Acute Physiology and Chronic Health Evaluation IV model for predicting in-hospital mortality in critically ill patients with sepsis.
DESIGN: Retrospective observational cohort study.
SETTING: Mixed ICU of Leiden University Medical Center, The Netherlands.
PATIENTS: Critically ill patients adult patients with sepsis who have been admitted to the ICU of Leiden University Medical Center, The Netherlands, from 2006 to January 2018.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We fitted a baseline model with the Acute Physiology and Chronic Health Evaluation IV predictors and added 13 prespecified combinations of lactate and lactate clearance at 0, 6 and 24 hours after admission to create a set of extended models to compare with the baseline Acute Physiology and Chronic Health Evaluation IV model. Among 603 ICU admissions, 451 patients met the inclusion criteria. A total of 160 patients died in-hospital, of which 106 died in the ICU. Their lactate and lactate clearance measurements were higher at all time points than those of survivors. The Akaike Information Criterion score improved in 10 of 13 prespecified extended models, with best performance for models that included lactate at 24 hours, alone or in combination with lactate at admission or lactate clearance at 24 hours. We compared the observed and predicted probabilities of in-hospital mortality of the baseline Acute Physiology and Chronic Health Evaluation IV model with the best model in our data, lactate at 24 hours added to the Acute Physiology and Chronic Health Evaluation IV model. This resulted in an increase in specificity of 29.9% (95% CI, 18.9-40.9%).
CONCLUSIONS: Lactate measurements at 24 hours after admission add predictive value to the prediction of mortality with Acute Physiology and Chronic Health Evaluation IV among ICU patients with sepsis. External validation is needed to develop extended prediction models.
参考来源
- Baysan M, Baroni GD, van Boekel AM, et al. The Added Value of Lactate and Lactate Clearance in Prediction of In-Hospital Mortality in Critically Ill Patients With Sepsis. Crit Care Explor. 2020. PMID: 32259110. doi:10.1097/CCE.0000000000000087
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。